NCT04841005

Brief Summary

COPD is a progressive disease associated with systemic inflammation, with many extrapulmonary outcomes such as cognitive impairment. Most of the daily activities involve doing several tasks at the same time, such as walking while talking or avoiding obstacles.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 2, 2021

Completed
4 days until next milestone

Study Start

First participant enrolled

April 6, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 12, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2022

Completed
Last Updated

March 3, 2022

Status Verified

February 1, 2022

Enrollment Period

11 months

First QC Date

April 2, 2021

Last Update Submit

February 15, 2022

Conditions

Outcome Measures

Primary Outcomes (5)

  • Change of the point in the cognitive test

    Montreal Cognitive Assessment will be used to evaluate cognitive impairment. The application time of the single-page scale is approximately 10 minutes and includes 6 cognitive functions.Cognitive functions evaluated in the scale are as follows: 1. Memory 2. Visual-spatial skills 3. Executive functions, 4. Attention, concentration and working memory tasks, 5. Language, 6. Orientation. The lowest score that can be obtained from the scale is 0, the highest score is 30.

    Two measurements: At the beginning and after eight weeks

  • Measurement of change in postural stability

    Postural stability is assessed using the Biodex Balance System. It consists of a mobile platform with 20 degrees of inclination in all directions and 12 levels of difficulty. With this system, balance is evaluated thanks to circular platforms that can oscillate simultaneously in the general, front-rear and left-right axes. The right-left stability indices are derived from the platform angular displacement in the frontal plane, while the anteroposterior angular displacement represents the platform displacement in the sagittal plane.

    Two measurements: At the beginning and after eight weeks

  • Measurement of change in functional balance

    The Balance Evaluation Systems Test (BESTest) will be used to evaluate functional balance. BESTest examines the balance in 6 sections in order to reveal whether the special balance control systems, which are defined as biomechanical structures, stability limits / verticality, intuitive postural adjustments, postural responses, sensory orientation and walking stability, function adequately. Since some of the tasks of BESTest have two subtitles, right side and left side, the patient is evaluated under 36 titles in total. In a sequential scale where each title is scored at 4 levels, 0 represents the worst performance, 3: the best performance. The total score of the test, which has a maximum of 108 points, can be calculated separately by calculating the percentage at the end of each section, as well as calculating the percentage of the total score.

    Two measurements: At the beginning and after eight weeks

  • Measuring change in quality of life

    St George's Respiratory Questionnaire (SGRQ) has been the most widely used quality of life measurement designed to evaluate the quality of life in lung diseases. SGRQ has distinctive (able to distinguish between different severity levels between patients) and descriptive (can detect disease progression and changes with treatment). The score range ranges from 0 (excellent health) to 100 (most severe disease) and the minimum clinically significant change is considered to be 4 units. This survey has good reproducibility in the short term. It consists of 50 questions in total. The numerical evaluation of the questionnaire is calculated in 4 separate sections as symptom score, activity score, impact score and total score.

    Two measurements: At the beginning and after eight weeks

  • Hospital Anxiety and Depression Scale

    It was developed to screen mood disorders in groups with a medical illness. It is a scale filled by the patient. It consists of 14 items. Substances contain 4 properties. Depression and anxiety are tried to be evaluated with the help of two subscales. The 7-item depression subscale has a scoring system between 0 and 21. The threshold value indicates "Normal" between 0-7, "Mild" between 8-10, "Moderate" between 11-14, "Severe" between 15-21.

    At the enrollment process

Secondary Outcomes (8)

  • Assessment of the COPD

    At the enrollment process

  • Assessment of comorbidities

    At the enrollment process

  • Evaluation of shortness of breath

    At the enrollment process

  • 1 Minute Sit and Stand Test

    Two measurements: At the beginning and after eight weeks

  • Forced expiratory volume in the first second

    At the enrollment process

  • +3 more secondary outcomes

Study Arms (2)

Square-Step Exercise group

EXPERIMENTAL

Square-step exercise for 8 weeks will be applied under the supervision of a physiotherapist.

Other: The Square-Step Exercise Training

Strengthening Exercise Group

EXPERIMENTAL

Strengthening exercise for 8 weeks will be applied under the supervision of a physiotherapist.

Other: Strengthening Exercise Training

Interventions

The Square-Step Exercise is instructed to walk according to the step pattern shown on a 100 \* 250 cm mat, divided into 40 squares of 25 cm each. It includes forward, backward, lateral and diagonal steps, and step patterns are progressively made more complex. Each pattern consists of two to 16 steps; Individuals are asked to repeat the step pattern until they reach the end of the mat. Each step pattern is repeated 4-10 times to ensure that individuals can complete the pattern. The individuals included in the study will exercise in easy-difficulty patterns for the first 2 weeks, medium-difficulty patterns in the 3rd and 4th weeks, medium and advanced patterns in the 5th and 6th weeks, and advanced patterns in the 7th and 8th weeks. The square-step exercise group will perform 15 minutes of warm-up exercise, 30 minutes of progressive square-step exercise, and 10 minutes of cool-down exercise accompanied by a physiotherapist, 3 days a week.

Square-Step Exercise group

Thera-Band brand elastic bands will be used to apply resistance in strengthening training. To determine the intensity of the exercise, the perceived difficulty level after 15 repetitions with the elastic band will be evaluated with the Borg scale. If the perceived difficulty level is at the level of 12-14 (slightly difficult), it will be considered as the starting difficulty level.In the strengthening exercise group will perform, shoulder abduction, shoulder press after elbow flexion, horizontal abduction, punching with an elastic band, triceps strengthening, external rotation of the shoulder, hip abduction with external rotation and sit-to-stand exercises for 8 weeks, 3 days / week , 3 sets / sessions, 8-12 repetitions. For each exercise, it will be applied as 8 repetitions in the initial workload. In the next exercise sessions, the number of repetitions will be increased until the patient can comfortably perform 12 repetitions with the same load.

Strengthening Exercise Group

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being diagnosed with mild / moderate COPD by Bolu Abant Izzet Baysal University Faculty of Medicine, Department of Chest Diseases.
  • Mini mental score is 23 or higher
  • Being between the ages of 50-80
  • Spirometric evaluation result is forced expiratory volume at one second / Forced vital capacity \<70% and airflow restriction is 50% forced expiratory volume at one second \<80% (expected) degree compared to post-bronchodilator forced expiratory volume at one second.
  • No drug change or antibiotic use due to acute exacerbation for at least three weeks

You may not qualify if:

  • Individuals who need continuous oxygen support
  • Individuals with partial pressure of carbon dioxide≥70 mmHg
  • Having a history of uncontrolled illness that may affect cognitive skills
  • Have uncorrected vision and hearing impairment
  • Having kyphoscoliosis and/or severe postural impairment
  • Having additional risk factors (stroke, neurological disease, dementia, depression, postural hypotension, diaphragm dysfunction)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bolu Abant Izzet Baysal University, Faculty of Health Sciences, Physiotherapy and rehabilitation department

Bolu, 14030, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveCognitive Dysfunction

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsCognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Alp Özel, MSc

    BAIBU, Faculty of Health Sciences, Physiotherapy and Rehabilitation Department

    PRINCIPAL INVESTIGATOR
  • Eylem Tütün Yümin, PhD

    BAIBU, Faculty of Health Sciences, Physiotherapy and Rehabilitation Department

    PRINCIPAL INVESTIGATOR
  • Suat Konuk, MD

    BAIBU, Faculty of Medicine, Department of Chest Diseases

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Exercises will be applied with the telerehabilitation method to the individuals included in the study. Video and audio communication will be provided by free and widely used programs such as Whatsapp or Telegram. Pulse oximetry, tripod and exercise material will be given to each individual included in the study by the researcher. Individuals included in the study will be randomly divided into two groups. Exercises in both groups will be done 3 days a week for 8 weeks. Before and after each exercise session, the heart rate and oxygen saturation values of the patients will be measured by pulse oximetry, and their perception of dyspnea and leg fatigue according to the Borg scale will be recorded. The first and last evaluation of individuals will be done face to face.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MSc,Research assistant

Study Record Dates

First Submitted

April 2, 2021

First Posted

April 12, 2021

Study Start

April 6, 2021

Primary Completion

February 15, 2022

Study Completion

February 15, 2022

Last Updated

March 3, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations